Have a feature idea you'd love to see implemented?
Let us know!
PMVP PMV Pharmaceuticals Inc
Price (delayed)
$1.61
Market cap
$83.31M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1
Enterprise value
$46.95M
PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are found in approximately half of all cancers.
Highlights
The EPS is up by 36% year-on-year but it has declined by 3.1% since the previous quarter
The company's net income rose by 29% YoY but it fell by 5% QoQ
The quick ratio is down by 28% YoY and by 28% QoQ
PMVP's equity is down by 17% year-on-year and by 8% since the previous quarter
Key stats
What are the main financial stats of PMVP
Market
Valuations
Earnings
Shares outstanding
51.75M
Market cap
$83.31M
Enterprise value
$46.95M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.42
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$67.57M
EBITDA
-$66.47M
Free cash flow
-$47.47M
Per share
Balance sheet
Liquidity
EPS
-$1
Free cash flow per share
-$0.92
Book value per share
$3.84
Revenue per share
$0
TBVPS
$4.33
Total assets
$223.5M
Total liabilities
$25.59M
Debt
$13.27M
Equity
$197.91M
Working capital
$176.06M
Debt to equity
0.07
Current ratio
13.98
Quick ratio
13.54
Net debt/EBITDA
0.55
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-21.7%
Return on equity
-24.2%
Return on invested capital
-35.3%
Return on capital employed
-32.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PMVP stock price
How has the PMV Pharmaceuticals stock price performed over time
Intraday
2.55%
1 week
0.63%
1 month
1.26%
1 year
-28.44%
YTD
-48.06%
QTD
8.05%
Financial performance
How have PMV Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$79.18M
Net income
-$51.47M
Gross margin
N/A
Net margin
N/A
The company's net income rose by 29% YoY but it fell by 5% QoQ
PMVP's operating income is up by 3.9% YoY but it is down by 2.9% from the previous quarter
Growth
What is PMV Pharmaceuticals's growth rate over time
Valuation
What is PMV Pharmaceuticals stock price valuation
P/E
N/A
P/B
0.42
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 36% year-on-year but it has declined by 3.1% since the previous quarter
PMVP's price to book (P/B) is 83% less than its 5-year quarterly average of 2.5 and 16% less than its last 4 quarters average of 0.5
PMVP's equity is down by 17% year-on-year and by 8% since the previous quarter
Efficiency
How efficient is PMV Pharmaceuticals business performance
The return on assets has increased by 23% year-on-year but it has declined by 10% since the previous quarter
The company's return on equity rose by 22% YoY but it fell by 10% QoQ
PMV Pharmaceuticals's ROIC has increased by 19% YoY but it has decreased by 9% from the previous quarter
Dividends
What is PMVP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PMVP.
Financial health
How did PMV Pharmaceuticals financials performed over time
The quick ratio is down by 28% YoY and by 28% QoQ
The current ratio has contracted by 27% from the previous quarter and by 27% YoY
The debt is 93% smaller than the equity
The company's debt to equity rose by 40% YoY and by 17% QoQ
PMVP's equity is down by 17% year-on-year and by 8% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.